Larimar Therapeutics (LRMR) Research & Development (2016 - 2019)
Historic Research & Development for Larimar Therapeutics (LRMR) over the last 6 years, with Q4 2019 value amounting to $423000.0.
- Larimar Therapeutics' Research & Development fell 9630.79% to $423000.0 in Q4 2019 from the same period last year, while for Dec 2019 it was $23.9 million, marking a year-over-year decrease of 5016.38%. This contributed to the annual value of $23.9 million for FY2019, which is 5016.38% down from last year.
- As of Q4 2019, Larimar Therapeutics' Research & Development stood at $423000.0, which was down 9630.79% from $5.3 million recorded in Q3 2019.
- Larimar Therapeutics' Research & Development's 5-year high stood at $17.7 million during Q4 2015, with a 5-year trough of $423000.0 in Q4 2019.
- For the 5-year period, Larimar Therapeutics' Research & Development averaged around $10.4 million, with its median value being $10.4 million (2015).
- As far as peak fluctuations go, Larimar Therapeutics' Research & Development soared by 21190.84% in 2015, and later plummeted by 9630.79% in 2019.
- Over the past 5 years, Larimar Therapeutics' Research & Development (Quarter) stood at $17.7 million in 2015, then crashed by 58.91% to $7.3 million in 2016, then skyrocketed by 49.98% to $10.9 million in 2017, then increased by 5.0% to $11.5 million in 2018, then crashed by 96.31% to $423000.0 in 2019.
- Its last three reported values are $423000.0 in Q4 2019, $5.3 million for Q3 2019, and $8.6 million during Q2 2019.